The increased manufacturing capacity from the Devens site will support marketplace demand for ORENCIA and positions us well for future production of additional biologic medicines. Bristol-Myers Squibb manufactures its biologic medicines in a currently company-owned facility in Syracuse, NY and through alternative party suppliers, and finishes and packages them in Manati, Puerto Rico. The Syracuse site will remain a key component of the business’s biologics strategy and will serve as a middle of excellence in procedure development and early product start for the business’s biologic medicines.If it does go to the requested jury trial, the known facts disclosed within that procedure become section of the public domain. These facts could incriminate Monsanto as a toxic menace publicly. Here’s the crux of the suit, which consists of minimal legalese and will be accessed here.[PDF] It promises what Roundup asserts in it’s label is fake. The label claims in large letters: ‘Did You Know? Glyphosate targets an enzyme found in plants however, not in people or house animals.’ It’ll be easy to verify it’s false, which is another good reason T. Matthew Phillips chose LA County Court rather than Federal Court. According to Phillips, California is pro-plaintiff when it comes to false advertising charges generally. Why the Roundup label can be falseThe enzyme Roundup targets is EPSP glyphosate synthase.